Chagas Disease Treatment Market, By Distribution Channel (Hospitals pharmacy and Retail Pharmacy) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

American trypanosomiasis also known as Chagas disease is caused by the parasite Trypanosoma cruzi (T.cruzi), which is transmitted by the bite of triatomine bugs. The parasites hide during the day time and become active at night and feed on human blood. T. cruzi can also be transmitted by food contaminated with the parasite, blood transfusion, transmission from infected mother to newborn during gestational period, organ transplant, and laboratory accidents. Its symptoms are not severe and are often not diagnosed. The parasites hide mainly in the heart and digestive muscles during the chronic phase. After years of chronic infection, it become an important cause of human heart diseases (30 %), megacolon, and megaseophagus. Chagas disease is one of the neglected parasitic infection in the U.S., however it is targeted by the Center for Disease Control and Prevention (CDC) for community health action. People living in rural part of Latin America are primarily affected by Chagas disease. It is mostly found in the 21 endemic regions of Latin American countries. According to a report by WHO, 2017, over the past few decades, there has been increase in the detection of chagas disease in Canada, European region, and western pacific countries mainly due to increasing influx in the population of Latin America According to Food and Drug Administration (FDA), in 2017, around 300,000 people are estimated to be affected by chagas disease in the U.S. Furthermore, World Health Organization (WHO) stated that, around 6 million to 7 million people are expected to be affected by chagas disease in 2017. Vector control is the most useful method to prevent the spread of Chagas disease in Latin America. High incidence rate and easy transmission mode is expected to increase the demand for treatment of Chagas disease. Non availability of vaccines and biological treatment, is expected to create opportunity for the market players. 

Chagas Disease Treatment Market Taxonomy  

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Unmet need of safe and effective drugs is expected to fuel the chagas disease treatment market growth

Countries like Venezuela have successful vector control program based on the improved rural housing and vector control. The use of nitro derivative compound drugs, which are associated with the host immune response, help to keep the disease in check and to avoid parasite proliferation.  None of the drug are able to completely cure the disease. Drugs used for the treatment of Chagas disease, benznidazole, and nifurtimox, have serious side effects such as headache, skin rashes, photosensitivity, chest pain, dizziness, nausea, insomnia, jaundice and among others. Medication with less side effects is the unmet need of the chagas disease treatment market. Active partnership of state and local health department to educate them the way to take care of patients, is expected to propel the chagas disease treatment market growth in the near future.

Approval of first safe and effective therapy for Chagas disease by FDA, expected to propel the market players to develop novel drugs

In 2017, Food and Drug Administration (FDA) approved benznidazole for use in children between the age 2 and 12 years affected from chagas disease. It is the first approved safe and effective therapeutics in U.S. for the chagas disease treatment. FDA granted benznidazole priority review and orphan product designation, as it is a rare disease and there have been no approved drugs for its treatment in U.S. This approval is expected to propel the manufacturers to develop new drugs and biological products for the prevention and treatment of rare disease.  Some of the major players operating in the global chagas disease treatment market include F. Hoffmann-La Roche Ltd., KaloBios Pharmaceuticals, Inc., Johnson & Johnson, Bayer AG., and ELEA SACIF Laboratory.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.